Heterogeneity of platelet functional alterations in patients with filamin A mutations

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):e11-8. doi: 10.1161/ATVBAHA.112.300603. Epub 2012 Nov 1.

Abstract

Objective: We examined platelet functions in 4 unrelated patients with filaminopathy A caused by dominant mutations of the X-linked filamin A (FLNA) gene.

Methods and results: Patients P1, P2, and P4 exhibited periventricular nodular heterotopia, heterozygozity for truncating FLNA mutations, and thrombocytopenia (except P2). P3 exhibited isolated thrombocytopenia and heterozygozity for a p.Glu1803Lys FLNA mutation. Truncated FLNA was undetectable by Western blotting of P1, P2, and P4 platelets, but full-length FLNA was detected at 37%, 82%, and 57% of control, respectively. P3 FLNA (p.Glu1803Lys and full-length) was assessed at 79%. All patients exhibited a platelet subpopulation negative for FLNA. Platelet aggregation, secretion, glycoprotein VI signaling, and thrombus growth on collagen were decreased for P1, P3, and P4, but normal for P2. For the 2 patients analyzed (P1 and P4), spreading was enhanced and, more markedly, in FLNA-negative platelets, suggesting that FLNA negatively regulates cytoskeleton reorganization. Platelet adhesion to von Willebrand factor under flow correlated with platelet full-length FLNA content: markedly reduced for P1 and P4 and unchanged for P2. Interestingly, von Willebrand factor flow adhesion was increased for P3, consistent with a gain-of-function effect enhancing glycoprotein Ib-IX-V/von Willebrand factor interaction. These results are consistent with a positive role for FLNA in platelet adhesion under high shear.

Conclusions: FLNA mutation heterogeneity correlates with different platelet functional impacts and points to opposite regulatory roles of FLNA in spreading and flow adhesion under shear.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Blotting, Western
  • Cell Shape / genetics
  • Collagen / metabolism
  • Contractile Proteins / genetics*
  • Crotalid Venoms / pharmacology
  • Cytoskeleton / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Fibrinogen / metabolism
  • Filamins
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Lectins, C-Type
  • Microfilament Proteins / genetics*
  • Muscular Dystrophies / blood*
  • Muscular Dystrophies / complications
  • Muscular Dystrophies / genetics*
  • Mutation*
  • Phenotype
  • Platelet Activation / drug effects
  • Platelet Activation / genetics*
  • Platelet Adhesiveness / genetics
  • Platelet Aggregation / genetics
  • Platelet Function Tests
  • Platelet Glycoprotein GPIb-IX Complex / metabolism
  • Platelet Membrane Glycoproteins / metabolism
  • Signal Transduction / genetics
  • Thrombocytopenia / blood
  • Thrombocytopenia / genetics
  • Thrombosis / blood
  • Thrombosis / genetics
  • von Willebrand Factor / metabolism

Substances

  • Contractile Proteins
  • Crotalid Venoms
  • Filamins
  • Lectins, C-Type
  • Microfilament Proteins
  • Platelet Glycoprotein GPIb-IX Complex
  • Platelet Membrane Glycoproteins
  • platelet membrane glycoprotein VI
  • von Willebrand Factor
  • convulxin
  • Fibrinogen
  • Collagen

Supplementary concepts

  • Filaminopathy, autosomal dominant